Fennec Pharma Revenue, Profits - FENC Quarterly Income Statement

Add to My Stocks
$8.23 $0.07 (0.84%) FENC stock closing price Sep 19, 2018 (Closing)

Looking at financial statements, along with the Fennec Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2018 Q2 impacts the FENC stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at Fennec Pharma assets, operating expenses and Fennec Pharma free cash flow. The Fennec Pharma profit and loss statement shows revenue of $- for 2018 Q2. Revenue has decreased by 0 QoQ for FENC stock.

View and download details of revenue and profits for Fennec Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Fennec Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Fennec Pharma Gross Profit
Research & Development Expense----------
Selling General & Admin Expense1.87M1.1M1.64M1.69M1.14M-----
Income Before Depreciation Depletion Amortization-2.67M-1.79M-2.53M-2.18M-1.47M-0.77M-1.16M-0.56M-0.7M-0.45M
Depreciation Depletion Amortization----------
Non Operating Income----0.16M-0.11M-0.03M---0.01M-
Interest Expense----------
Fennec Pharma Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.59M-1.57M-2.29M-2.35M-1.6M-0.81M-1.14M-0.5M-0.72M-0.42M
Extraordinary Items & Discontinued Operations----------
Fennec Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS18.59M17.42M15.27M15.74M14.19M13.43M14.29M13.64M12.07M10.5M
Average Shares used to compute Basic EPS18.59M17.42M15.27M15.74M14.19M13.43M14.29M13.64M12.07M10.5M
Income Before Nonrecurring Items-2.59M-1.57M-2.29M-2.35M-1.6M-0.81M-1.14M-0.5M-0.72M-0.42M
Income from Nonrecurring Items----------
Fennec Pharma Earnings Per Share Basic Net
Fennec Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.14-0.09-0.15-0.15-0.11-0.06-0.08-0.04-0.06-0.04
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Fennec Pharma stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2018 Q2. Our Fennec Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. FENC stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the FENC income statement, one can check the Fennec Pharma historical stock prices to check how the price has moved with time.

Fennec Pharma Income Statement - Key Financial Ratios